<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>MOLECULAR CELLULAR BIOLOGY, 1999, p. 3312&#226;&#8364;&#8220;3327                                                                             Vol. 19,  5 <br /> 0270-7306/99/$04.0010 <br /> Copyright &#194;&#169; 1999, American Society Microbiology. Rights Reserved. <br />  <br />  <br />  <br />            NDD1, High-Dosage Suppressor cdc28-1N, Essential <br />              Expression Subset Late-S-Phase-Specific <br />                       Genes Saccharomyces cerevisiae <br />                                 CHONG JIN LOY,1 DAVID LYDALL,2                        UTTAM SURANA1* <br />             Institute Molecular Cell Biology, National University Singapore, Singapore 117609, Singapore,1                    School Biological Sciences, University Manchester, Manchester M13 9PT, United Kingdom2 <br />                       Received 29 October 1998/Returned modification 3 December 1998/Accepted 25 January 1999 <br />  <br />              cdc28-1N mutants progress G1 S phases normally restrictive temperature fail           undergo nuclear division. isolated gene, NDD1, high dosage suppresses nuclear- <br />           division defect cdc28-1N. NDD1 (nuclear division defective) essential gene. expression           cell cycle tightly regulated NDD1 RNA abundant S phase. Cells lacking           NDD1 gene arrest elongated bud, short mitotic spindle, 2N DNA content, undivided nucleus, <br />           suggesting function required aspect nuclear division. overexpression           Ndd1 results upregulation CLB1 CLB2 transcription, suggesting suppression           cdc28-1N NDD1 accumulation cyclins. Overproduction Ndd1 enhances           expression SWI5, transcription, like CLB1 CLB2, activated late S phase. Ndd1 <br />           essential expression CLB1, CLB2, SWI5, genes transcribed           absence. CLB2 expression upregulation NDD1 mediated 240-bp promoter sequence <br />           contains MCM1-binding sites.  Ndd1 does appear component protein <br />           complexes assembled DNA fragment, indicated gel mobility shift assays. Instead, overexpression <br />           NDD1 prevents formation complexes appearance correlates termination           CLB2 expression G1. inability GAL1 promoter-driven CLB2 suppress lethality NDD1 null <br />           mutant suggests  addition CLB1 CLB2, NDD1 required transcription           genes functions necessary G2/M transition. <br />  <br />  <br />    orderly progression cell division cycle                  genes regulated sequence motif called SCB <br /> quires relevant cellular events occur strict tem-               (Swi4/Swi6 cell cycle box) promoter (22). poral sequence. budding yeast Saccharomyces cerevisiae,                motif promoters genes encoding HO organisms, achieved combination                 endonuclease cyclin-like protein Hcs26 (6, 11), transcriptional posttranslational regulations various               expressed late G1. specific heteromeric transcrip- <br /> effectors. best-studied examples posttrans-                tion factor complex (SCF) containing Swi4 Swi6 proteins <br /> lational controls way activity key                 drives cell cycle stage-specific expression binding protein kinase Cdc28 regulated. Phosphorylation specific                SCB element (37, 38). S-phase cyclin genes CLB5 tyrosine threonine residues (19, 34, 35, 49), association             CLB6 DNA synthesis genes POL1, TMP1, variety cyclins (14, 43, 48, 53), proteolytic             CDC9 expressed late G1 expression destruction various stages cell cycle (2, 3, 10, 18)            driven promoter element called MCB (Mlu1 cell <br /> contribute sharply define timing Cdc28                     cycle box) binds transcription factor complex (MBF) <br /> activation-inactivation  presumably, substrate spec-             containing Mbp1 Swi6 (23, 28). onset S <br /> ificity (35). Similarly, anaphase-promoting complex                  phase, histones  somewhat later, CLB3 CLB4 cyclin <br /> activity crucial chromosome segregation appears                  genes transcribed (15). <br /> regulated posttranslational level (24, 54, 55).                           transcription set genes activated near <br />    posttranslational modifications mitotic reg-               completion S phase. includes FAR1, protein <br /> ulators effective way cell                    required pheromone-induced G1 arrest, transcription <br /> quickly respond changing cellular context,                    factors SWI5 ACE2, mitotic cyclin genes CLB1 CLB2, <br /> sponses sharpened controls transcrip-                CDC5, gene encoding Polo-like protein kinase. tional level.  estimated DNA microarray                 clear periodic expression genes regu- <br /> hybridization 800 genes budding yeast S.                    lated common promoter element transcription fac- <br /> cerevisiae transcribed specific stages cell cycle          tors. analysis SWI5 promoter revealed 55-bp element <br /> (50). periodically transcribed genes play crucial               sufficient periodic expression SWI5 (29). roles cell cycle progression. instance, transcripts                                                                               proposed Mcm1, DNA-binding protein important G1 cyclins CLN1 CLN2 appear late G1 phase ap- <br />                                                                               determination mating-type specificity, forms com- <br /> proximately cells traverse START. transcription <br />                                                                               plex Sff (SWI5 transcription factor) binds 55-bp <br />                                                                               promoter element (29). gene encoding Sff   * Corresponding author. Mailing address: Institute Molecular             identified. subsequent studies, shown Mcm1 Cell Biology, 30, Medical Dr., Singapore 117609, Singapore.               required expression CLB1, CLB2, SWI5, CDC5, Phone: (65) 7743612. Fax: (65) 7791117. E-mail: mcbucs@imcb.nus               ACE2 (1, 30). consistent fact promoter <br /> .edu.sg.                                                                      regions CLB1, CLB2, SWI5 contain consensus Mcm1 <br />  <br />                                                                        3312 <br />  VOL. 19, 1999                                                                                     REGULATION LATE-S-PHASE GENES                               3313 <br />  <br />  <br />                           TABLE 1. Yeast strains                                    yeast extract-peptone medium containing <span id='am-16' about='obo:IMR_0200350' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-17' property="rdfs:label" content="Adenine" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasDbXref" content="KEGG:C00147" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:id" content="IMR:0200350" datatype="xsd:string"></span>adenine</span> (50 mg/liter) supplemented <br />                                                                                     glucose galactose. Raffinose added galactose <br />  Strain                                Relevant genotype                            medium. media prepared described Rose et al. (44). <br />                                                                                        obtain cultures synchronized G1, bar1D cells (US356) treated W303            MATa ade2-1 trp1-1 can1-100 leu2-3 his3-11 ura3                     factor (0.8 mg/ml) 3 h. experiments synchronous release US100           MATa cdc28-4 ade2-1 trp1-1 can1-100 leu2-3 his3-11                  late telophase required, cdc15 cells grown log phase 24&#194;&#176;C                  ura3                                                               filtered resuspended prewarmed growth medium 37&#194;&#176;C. US102           MATa cdc28-1N ade2-1 trp1-1 can1-100 leu2-3 his3-11                 3 h, cells allowed resume cell cycle progression 24&#194;&#176;C. <br />                  ura3                                                                  Isolation NDD1. cdc28-1N cells transformed library yeast <br />                                                                                     genomic fragments cloned BamHI site YEp13 (2mm) vector (36), <br /> US239           MATa ade2-1 trp1-1 can1-100 leu2-3 his3-11 ura3 <br />                                                                                     allowed recover 24&#194;&#176;C 24 h, shifted 37&#194;&#176;C 3 days. US241           MATa NDD1/ndd1D::LEU2 ade2-1 trp1-1 can1-100                      plasmids retrieved various transformants categorized                  leu2-3 his3-11 ura3                                                seven distinct groups based patterns fragments generated restriction <br /> US262           MATa ndd1D::LEU2 pGAL1-NDD1 ade2-1 trp1-1                           enzyme digestion. group plasmids harbored 2.7-kb PvuII genomic <br />                  can1-100 leu2-3 his3-11 ura3                                       fragment containing NDD1 gene. <br /> US356           MATa ade2-1 trp1-1 can1-100 leu2-3 his3-11 ura3                        DNA manipulations. DNA manipulations performed described                  bar1D::hisG                                                        Sambrook et al. (46). 2.7-kb PvuII fragment containing entire NDD1 <br /> US449           MATa gal4 gal80 his3 ade2-101 trp1-901 leu2-3 ura3-52               gene blunt-end cloned SmaI-BglII site pIC19H vector yield <br />                  URA3::GAL1-lacZ LYS2::GAL1-HIS3, Y190                              pUS529. construct NDD1 gene control GAL1 promoter,                                                                                     NcoI site created immediately upstream ATG start codon PCR. <br /> US737           MATa ade2-1 trp1-1 can1-100 leu2-3 his3-11 ura3                     BamHI-BglII fragment pUS529 replaced BamHI- <br />                  bar1D::hisG pGAL1-NDD1                                             BglII-digested 0.97-kb PCR product. complete NDD1 gene excised <br /> US1005          MATa prc1-407 prb1-1122 pep4-3 leu2 trp1 ura3-52                    NcoI-HindIII blunt-end ligated GAL1 promoter URA3-                  gal2 (BJ2168)                                                      TRP1-selectable CEN vector. <br /> US1013          MATa prc1-407 prb1-1122 pep4-3 leu2 trp1 ura3-52                       Gene disruptions performed using step gene replacement <br />                  gal2 pGAL1-HA3-NDD1                                                method Rothstein (45) 2.7-kb PvuII fragment 450-bp <br /> US1052          MATa mcm1 ade2-1 leu2-3 his3-11                                     EcoRV fragment open reading frame (ORF) replaced 1.6-kb <br /> US1139          MATa ndd1D:LEU2 pGAL1-HA3-NDD1 ade2-1 trp1-1                        XhoI-SalI fragment containing LEU2 gene. disruption NDD1 gene <br />                                                                                     confirmed Southern blot analysis. tag NDD1 tandem copies <br />                  can1-100 leu2-3 his3-11 ura3 pep4D::URA3                           hemagglutinin (HA) epitope (GRIFYPYDVPDYAGYPYDVPDYAG- <br /> US1354          MATa cdc15 ade2-1 trp1-1 can1-100 leu2-3 his3-11                    SYPYDVPDYAAQC), NotI site introduced just ATG start <br />                  ura3 pGAL1-HA3-NDD                                                 codon PCR. triple HA tag  111-bp NotI fragment) cloned                                                                                     newly created NotI site. resulting HA3-tagged NDD1 excised                                                                                     NcoI-SmaI fragment blunt-end ligated GAL1 promoter TRP1- <br />                                                                                     selectable CEN vector yield pGAL1-HA3-NDD1. <br /> binding sites. Interestingly, Mcm1 occupies sites                        test upstream activation sequence (UAS) activity, CLB2 promoter <br />                                                                                     sequences cloned upstream CYC1 TATA box fused ubiY lacZ cell cycle, implying timing expression                       reporter, expresses b-galactosidase activity half-life 10 min determined specific modifications                          instead 20 h (8). 340-bp CLB2 UAS (extending 2863 bound factors associated factors (1).                       2523 bp ATG) generated PCR cloned XhoI-BglII site <br /> recently reported novel promoter element ECB (early                          pDL1498 plasmid containing ubiY lacZ reporter (29) SalI-BglII <br />                                                                                     fragment (sites introduced PCR). 240-bp CLB2 UAS (2863 2627 bp <br /> cell cycle box), renders expression SWI4, CDC6,                        ATG) dropping 110-bp XhoI-BglII fragment CDC47, CDC46 M/G1 specific, binds Mcm1 (32).                               340-bp CLB2 UAS reporter construct religating plasmid. 55-bp Mcm1 involved regulation cellular                     CLB2 UAS (2698 2643 bp ATG) synthesized mutually priming <br /> processes directly linked cell cycle progres-                   oligonucleotides (59-TACAGAATTCTCGAGAATATAGCGACCGAATC <br />                                                                                     AGGAAAAGGTCAACAACGA-39 59-ACTGAATTCAGATCTCATCCA <br /> sion (26, 31, 33, 51), unlikely Mcm1 critical                  TATCGCGAACTTCGTTGTTGACCTTTTCC-39) described Ausubel et <br /> factor determining periodicity gene expression.                           al. (7) cloned pDL1498 XhoI-BglII fragment (sites introduced    Cdc28 key protein kinase required various stages                    PCR). recombinant reporter constructs excised SmaI-NcoI diges- cell cycle progression, CDC28 mutants exhibit defects                      tion blunt-end cloned EcoRI site URA3-based integrative <br />                                                                                     plasmid subsequently integrated URA3 locus homologous recom- progression START G2/M transition (39,                          bination. integration events checked Southern blot analysis, 41).  cdc28-1N unique mutant                          b-galactosidase activities measured independent isolates <br /> normal respect START functions, fails undergo                     integrative transformation. Activities expressed Miller units. <br /> nuclear division restrictive temperature  conse-                            clone length NDD1 frame GAL4 DNA-binding domain <br />                                                                                     pGBT9 (9), NDD1 excised pUS529 NcoI-XhoI fragment quently, arrests large elongated bud, short mitotic                        blunt-end ligated SmaI site pGBT9. GAL4-NDD1 deletion mu- <br /> spindle, 2N DNA content, high histone H1 kinase activity,                       tant analysis, constructs similarly different restriction undivided nucleus (39, 53). molecular nature                        enzymes used excise various NDD1 fragments pUS529. mitotic defect unknown, cdc28-1N mutant                     isolated fragments subsequently cloned frame pGBT9 yield                                                                                     various GAL4-NDD1 deletion fusion constructs  Table 2). NDD1 lacking served identification number novel genes.                      polyglutamine domain constructed PCR following sets prim- <br /> CLB1, CLB2, CLB4 isolated allele-specific,                        ers: 59-TTGATTGGATCCATGGACAGAGATATAAGC-39 59-TCTGCT <br /> high-dosage suppressors cdc28-1N mutation (53). Sim-                         GATGCTGCAGTAATATAC-39 obtain sequence 59 polyglutamine <br /> ilarly, CIM3 CIM5 genes encoding 26S proteosome                             domain 59-TTCTTCTGTTCTGCAGTTCGGCAAC-39 59-TATTGTT <br />                                                                                     AGATCTTAGCGGCGTTCT-39 obtain sequence 39 polyglutamine <br /> subunits identified mutations exhibit synthetic <br />                                                                                     domain. PCR products digested NcoI-PstI PstI-BglII lethal behavior combination cdc28-1N (17). report                        triple ligated NcoI-BglII-cut pUS529. resulted NDD12DQ  isolation novel allele-specific, high-dosage sup-                     struct lacks amino acids 93 143. construct subsequently excised <br /> pressor cdc28-1N, termed NDD1, examine role cell                      NcoI-XhoI fragment blunt-end ligated frame GAL4 DNA- <br /> cycle progression. basic characterization                       binding domain pGBT9. <br />                                                                                        Random spore analysis. determine terminal phenotype cells defi- NDD1 essential component, MCM1,                        cient NDD1, diploid strain heterozygous ndd1D::LEU2 (US241) mechanism activates expression set late-S-                         sporulated liquid medium. Spores purified centrifugation (7) inocu- <br /> phase-specific genes.                                                               lated medium lacking leucine. Samples withdrawn 6 h germina- <br />                                                                                     tion used situ immunofluorescence photomicroscopy. <br />                                                                                        Gel mobility shift assay. Yeast protein extracts prepared protease- <br />                         MATERIALS METHODS                                       deficient (pep42) strains essentially described Company et al. (12). Double- <br />   Yeast strains growth media. Yeast strains (Table 1) used study   stranded DNA probes prepared using Klenow enzyme derivatives standard wild-type strain W303. Strain BJ2168 (US1005)       protruding 59 end restriction site presence radioactive  32P]<span id='am-6' about='obo:IMR_0200129' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-7' property="rdfs:label" content="dATP" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:id" content="IMR:0200129" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasDbXref" content="KEGG:C00131" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>dATP</span>. <br /> used mobility shift DNA-binding assay. Yeast cells routinely grown      labelled probes purified unincorporated nucleotides using <br />  3314       LOY ET AL.                                                                                                                           MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />    FIG. 1.   NDD1 allele-specific suppressor cdc28-1N mutation. cdc28-4 cdc28-1N cells transformed YEp13 (2mm) vector <br /> containing NDD1 2.7-kb PvuII fragment. transformants plated leucine-deficient plates incubated 24 37&#194;&#176;C 48 h. (B) <span id='am-21' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-22' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-25' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span>Nucleotide</span> sequence predicted <span id='am-29' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-30' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-31' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-33' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span>amino acid</span> sequence NDD1. polyglutamine stretch shown boldface, conserved cdc2/CDC28 histone H1 phosphorylation <br /> sites underlined. <br />  <br />  <br />  <br /> NucTrap probe purification columns (Stratagene). DNA binding reactions          suppress cdc28-4 mutation (Fig. 1A). Overexpression carried 1.5-ml Eppendorf tubes. Generally, 10,000 20,000 cpm (Ceren-       NDD1 failed suppress cdc28-4 mutation kov) probe used reaction. reaction contained 4 ml 53 BS <br /> buffer (100 mM Tris-HCl [pH 7.5], 250 mM NaCl, 15 mM MgCl2, 5 mM                     tested 31 35&#194;&#176;C (data included).  NDD1 dithiothreitol, 25 mM <span id='am-36' about='obo:IMR_0200175' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-37' property="oboInOwl:hasDbXref" content="KEGG:C00315" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:id" content="IMR:0200175" datatype="xsd:string"></span><span id='am-39' property="rdfs:label" content="Spermidine" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>spermidine</span>, 250 mg bovine serum albumin ml, 100         allele-specific suppressor cdc28-1N mutation.  <br /> mM EDTA), 2 ml 50% glycerol, 2.5 ml 1-mg/ml concentration poly(dI-        havior identical mitotic cyclin genes CLB1 dC), radiolabelled probe, water, 20 mg protein extract final        CLB2, isolated screening (53). volume 20 ml. Protein extracts added  reactions incubated 24&#194;&#176;C 15 min followed 15 min incubation 4&#194;&#176;C.      suggests role NDD1 related mitotic func- <br /> Conditions competition experiments exactly cold        tion CDC28. <br /> competitor DNAs added reaction mixture addition               NDD1 gene, located chromosome XV, contains 1.66-kb <br /> radiolabelled probe. antibody supershift assays, appropriate antibodies added 6 min addition protein extracts processed                                                                                      ORF (Saccharomyces Genome Database ORF sequence <br /> described  gel used resolving protein-DNA complexes 4%         YOR372c) encodes protein 554 amino acids (Fig. 1B) <br /> (20:1) acrylamide-bisacrylamide gel 0.53 Tris-borate-EDTA (TBE). gels         significant overall homology known protein prerun 4&#194;&#176;C 2 h 200 V (;20 mA) 0.53 TBE. incubation,          databases. protein contains unbroken stretch 15 reaction mixtures loaded gel run 4&#194;&#176;C 3 h 200 V <br /> (;8 mA). gels dried autoradiographed intensifying screen <br />                                                                                      glutamine residues N terminus. glutamine stretches 270&#194;&#176;C.                                                                            number proteins diverse functions, <br />    techniques. lithium acetate method used yeast transfor-     including transcription activators, precise role <br /> mations. Total RNA isolated described Cross Tinkelenberg (13),         motif serves proteins known. Northern (RNA) blot analyses performed described Price et al. <br /> (40). method Kilmartin Adams (21) used immunofluores- <br />                                                                                      case Ndd1, glutamine tract does play cence photomicroscopy. DNA distribution analysis flow cytometry           crucial role Ndd1 function, Ndd1 lacking stretch <br /> performed described Lim et al. (27).                                           complement NDD1-null mutant able sup- <br />                                                                                      press cdc28-1N mutation  . Ndd1 contains                                  RESULTS                                             putative Cdc28 phosphorylation sites middle region,                                                                                      relevance Ndd1 function clear.   NDD1 allele-specific suppressor cdc28-1N mu-                          features match known motifs, amino <br /> tation. CDC28 mutants  e., cdc28-1, cdc28-4, cdc28-                       acid sequence Ndd1 currently provides clues pos- <br /> 13) predominantly defective traversing START                              sible function. arrest late G1 phase unbudded cells 1N                             NDD1 essential gene function required DNA content (20, 42). exhibit defect                          mitosis. determine NDD1 necessary cell <br /> progression mitosis (39, 41). cdc28-1N mutant                         viability, ORF copies NDD1 unique progresses START S phase                               wild-type diploid replaced LEU2 gene (Fig. 2A). <br /> normally fails undergo nuclear division nonper-                        resulting heterozygous mutant (US241) allowed missive temperature, despite high Clb2-associated histone                        sporulate, tetrads dissected rich medium. H1 kinase activity (39, 53). isolated NDD1 genetic                           spores tetrad survived gave rise normal <br /> screen designed identify genes overexpression                           colonies failed grow replica plated leucine- <br /> suppress mitotic defect cdc28-1N mutant. determine                         deficient medium. inference, absence viable Leu1 NDD1 overexpression causes suppression                              segregants dissections suggests segregants cdc28 mutations, high-copy-number (2mm) vector carrying                            Leu1 lacked intact NDD1 ORF non- <br /> NDD1 introduced cdc28-4 cdc28-1N mu-                               viable. Microscopic examination segregants revealed <br /> tants, transformants tested growth 37&#194;&#176;C.                         spores germinated arrested NDD1 allowed growth cdc28-1N cells 37&#194;&#176;C, failed                       large-budded cells, undergone  VOL. 19, 1999                                                                REGULATION LATE-S-PHASE GENES               3315 <br />  <br />  <br />  <br />  <br />                                                          FIG. 1&#226;&#8364;&#8221;Continued. <br />  <br />  <br />  <br />  <br /> divisions cessation growth. suggests NDD1      grown galactose transferred glucose essential vegetative growth.                                medium. end 6 h, cells arrested,    characterize cell cycle arrest phenotype NDD1-        phenotype identical observed spore outgrowth <br /> deficient cells, diploid cells heterozygous NDD1 disruption    experiment. Fluorescence-activated cell sorter analysis showed <br /> (US241) grown YPD medium transferred           cells arrested 2N DNA content (Fig. 2B). <br /> sporulation medium. 20 h, spores purified            NDD1-deficient cells capable bud emergence, <br /> inoculated medium lacking leucine allow germination        DNA replication, spindle formation, fail pro- growth spores NDD1 ORF          ceed anaphase. suggests NDD1 essential replaced LEU2 gene. Immunofluorescence micros-         aspect nuclear division. <br /> copy revealed NDD1-deficient cells arrested large,        Expression localization Ndd1 cell cycle. <br /> elongated bud, undivided nucleus, short mitotic spin-     NDD1 appeared necessary nuclear division <br /> dle (Fig. 2B). parallel experiment, NDD1-deficient haploid    process, asked expression restricted cells kept alive CEN vector carrying GAL-NDD1 (US262)         stage cell cycle. Exponentially growing wild-type cells <br />  3316       LOY ET AL.                                                                                                                              MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />    FIG. 2. NDD1 essential gene.   Partial restriction map 2.7-kb PvuII fragment containing NDD1. 0.45-kb EcoRV fragment ORF replaced LEU2 gene generate disruption mutant ndd1D::LEU2. scale bar base pairs. Diploid cells heterozygous ndd1D::LEU2 disruption sporulated dissected rich medium. Tetrads 2:2 segregation pattern viability. survivors Leu2. (B) Cell cycle arrest phenotype ndd1D. Spores wild-type diploid strain ndd1D::LEU2 heterozygous diploid strain purified germinated complex medium medium lacking leucine, <br /> respectively. Samples withdrawn 6 h germination used differential-interference-contrast (DIC) microscopy, staining anti-tubulin antibodies, DAPI (49,6-diamidino-2-phenylindole) staining. lower panel shows DNA distribution profiles asynchronously growing wild-type Ndd1-depleted cells. <br />  VOL. 19, 1999                                                                  REGULATION LATE-S-PHASE GENES                 3317 <br />  <br />  synchronized G1 factor treatment 3 h 25&#194;&#176;C       RNAs NDD1 overexpression abolishes cell allowed resume cell cycle progression factor-      cycle regulation cyclins constitutively <br /> free medium. Total RNA isolated, NDD1-specific              expressed response excess Ndd1. test  cdc15 cells <br /> transcript detected Northern blot analysis. NDD1         carrying GAL-NDD1 CEN vector (US1354) grown RNA, detectable basal level 30 min     raffinose medium 25&#194;&#176;C synchronized telophase <br /> release G1 arrest, peaks 50 60 min declines     incubation 37&#194;&#176;C 2 h. Cells induced produce <br /> ca. 30 min majority cells reach anaphase (Fig.        NDD1 2 h addition galactose 3A). transcript appears cycle        allowed resume cell cycle progression 25&#194;&#176;C ga- <br /> proportion cells anaphase spindle reached min-      <span id='am-1' about='obo:IMR_0200277' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-2' property="rdfs:label" content="Lactose" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasDbXref" content="KEGG:C00243" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:id" content="IMR:0200277" datatype="xsd:string"></span>lactose</span> medium. control experiment, cdc15 cells carrying imum. window NDD1 expression lies peaks          vector GAL-NDD1 subjected identical ex- CLN1 CLB2 transcription (Fig. 3A), period             perimental regimen. released telophase arrest, <br /> corresponds S phase. clear          cdc15 cells traverse cell cycle highly synchronous man- <br /> restricts NDD1 transcription S phase. far     ner (52). Total RNA prepared various time points known cis-regulatory elements 2-kb          analyzed presence CLB2 transcript Northern <br /> gion upstream ORF loosely conserved SCB           blotting. expected, CLB2 expression cells GAL- <br /> (Swi4/Swi6 cell cycle box) reverse orientation.                  NDD1 showed characteristic undulation switched <br />    determine cellular location Ndd1 protein, NDD1-        30 min release telophase turned ORF fused frame gene encoding b-galactosi-          cells cycle (Fig. 4B). dase control GAL1 promoter CEN            overexpression NDD1 GAL1 promoter does plasmid. fusion construct fully functional,        change pattern; instead causes  fivefold  <br /> NDD1 null mutant harboring plasmid grew normally            crease overall expression CLB2 (Fig. 4B).  <br /> galactose remained nonviable glucose medium. Wild-           excess NDD1 amplifies CLB2 expression does ab- <br /> type cells carrying fusion construct grown galactose    rogate cell cycle regulation. <br /> medium 3 h fixed <span id='am-41' about='obo:IMR_0200017' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-42' property="oboInOwl:hasDbXref" content="KEGG:C00067" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-44' property="rdfs:label" content="Formaldehyde" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:id" content="IMR:0200017" datatype="xsd:string"></span>formaldehyde</span>. Immuno-               NDD1 essential CLB1, CLB2, SWI5 expression. <br /> fluorescence staining anti-b-galactosidase antibodies          Ndd1 modulate expression CLB1, CLB2, showed brightly stained nuclei (Fig. 3B). nuclear staining       SWI5, asked NDD1 essential transcrip- observed cells expressing b-galactosidase          tion genes. efforts isolate &#226;&#8364;&#339;tight&#226;&#8364;? tem- <br /> GAL1 promoter  shown). implies Ndd1              perature-sensitive allele NDD1 successful, used <br /> nuclear protein (Fig. 3B). protein seen       experiments ndd1D strain kept alive CEN <br /> nucleus, irrespective bud size state         plasmid carrying GAL-NDD1 (US262). transferred nuclear division, suggesting nuclear localization Ndd1   glucose medium, strain exhibits arrest phenotype cell cycle stage dependent.                             4 5 h. cells grown galactose    Overexpression Ndd1 enhances expression CLB1,          reached log phase shifted glucose medium CLB2, SWI5 genes. known elevated levels       switch NDD1 expression. Total RNA isolated B-type cyclins Clb1, Clb2, Clb4 suppress nuclear        samples withdrawn various time intervals analyzed division defect cdc28-1N mutant (53). reasoned       presence CLB1, CLB2, SWI5, CLB3, CDC20, NDD1, gene overexpression cause accumulation         URA3 RNAs Northern blotting. cells began cyclins, upregulation transcription        exhibit characteristic terminal phenotype 5 h increasing stabilization, identified     remained arrested 2N content DNA, short <br /> genetic screen.  tested NDD1 ability        mitotic spindle, undivided nucleus. CLB3, <br /> enhance transcription CLB1 CLB2. Wild-type cells         CDC20, URA3 transcripts present carrying GAL-NDD1 CEN plasmid (US737) grown               course experiment, CLB1, CLB2, SWI5 RNAs raffinose medium  GAL1 promoter active)          undetectable 4 h shifting glucose medium 3 h half culture induced express     remained remainder time course (Fig. <br /> Ndd1 addition galactose. Total RNA prepared        5A). expected, NDD1 transcribed pe- <br /> various time points analyzed presence CLB1,          riod. results suggest NDD1 essential tran- <br /> CLB2, CLB3, SWI5, CDC20, NDD1 transcripts.             scriptional activation CLB1, CLB2, SWI5 genes CLB1, CLB2, SWI5, CDC20 genes transcribed            expression CLB3 CDC20. <br /> late S/G2 phase, CLB3 expressed slightly earlier            Clb1 Clb2 B-type cyclins associate (22). transcription CLB1, CLB2, SWI5 continues           protein kinase Cdc28 govern mitotic activity (16, 53). mitosis switched cells exit       Cells lacking CLB1 CLB2 viable clb1D <br /> mitosis (29, 53). URA3 served internal control equal      clb2D double mutant unable proceed mitosis RNA loading transcribed constitutively       arrest short spindle, undivided nucleus, 2N DNA <br /> cell cycle. overexpression NDD1 did cause            content (53). phenotype similar change level CLB3, CDC20, URA3 tran-              ndd1D mutant. NDD1 required CLB1 CLB2 <br /> scripts.   fivefold increase    transcription, possible nonviability ndd1D mu- <br /> steady-state levels CLB1 CLB2 RNA (Fig. 4A).             tant entirely lack mitotic cyclins. SWI5 expression noticeably enhanced (Fig. 4A).             test  performed plasmid shuffle experiment CDC5 ACE2 genes expressed             TRP1-selectable CEN plasmid carrying GAL-CLB2 late-S/G2 phase, expression affected        GAL-NDD1 introduced ndd1D mutant kept alive <br /> overexpression NDD1 (data shown).  NDD1 mod-            native-promoter-driven NDD1 URA3-selectable <br /> ulates expression subset late-S/G2 genes.    vector. transformants plated galactose medium <br /> data suggest ability NDD1 suppress          containing 5-fluoro-<span id='am-11' about='obo:IMR_0200265' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-12' property="rdfs:label" content="Orotic acid" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:id" content="IMR:0200265" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasDbXref" content="KEGG:C00295" datatype="xsd:string"></span>orotic acid</span> (5-FOA) select clones <br /> cdc28-1N mutation linked capacity augment      lost URA3 vector bearing NDD1 ex- expression mitotic cyclins CLB1 CLB2.                pressed GAL-NDD1 GAL-CLB2. cells <br />    increase steady-state level CLB1 CLB2          containing GAL-NDD1 grew readily 5-FOA plates,  3318       LOY ET AL.                                                                                                                          MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />    FIG. 3.   NDD1 gene expression cell cycle. Wild-type cells lacking BAR1 gene arrested G1 factor treatment released growth <br /> medium factor. Samples withdrawn 10-min intervals, total RNA analyzed Northern blotting internal EcoRI fragment NDD1 probe. CLN1 CLB2 RNA transcripts shown comparison. total RNA loaded (30 mg) visualized methylene blue staining rRNAs. graph shows percentage cells anaphase spindles release. (B) Nuclear localization Ndd1-lacZp. Wild-type cells <br /> carrying pGAL1-NDD1-lacZ grown glucose galactose medium used indirect immunofluorescence staining anti-b-galactosidase <br /> antibodies (upper panels) nuclear staining DAPI (lower panels). <br />  <br />  <br />  <br /> strain harboring GAL-CLB2 did rise colonies                         tivated late-S/G2 phase cell cycle (1). light <br /> (Fig. 5B), suggesting Clb2 overexpression                         observation NDD1 required transcription <br /> compensate absence Ndd1.  lethality                            subset genes activate transcription <br /> caused NDD1 deficiency solely lack                          yeast hybrid assay, possible NDD1 interacts <br /> mitotic cyclins. implies  addition CLB1                         functionally MCM1.  multicopy vector (2mm) <br /> CLB2, NDD1 required expression                         carrying native-promoter-driven NDD1, able genes function necessary G2/M transition.                          support growth mcm1 mutant cells 37&#194;&#176;C, does allow <br />    Transcriptional activation NDD1. results raise                      grow 35&#194;&#176;C (1a).  excess NDD1 able possibility Ndd1 transcription activator,                      suppress, extent, lethality caused lack tested ability activate transcription heterologous                      Mcm1 function. <br /> context using yeast hybrid assay. NDD1 coding                             Normal periodic transcription CLB2 requires 240-bp <br /> region, fused frame DNA-binding domain                           promoter sequence. Maher et al. (30) described 55-bp <br /> transcription factor GAL4, control                         UAS CLB2 promoter contains consensus <br /> ADH promoter transformed tester strain                          Mcm1 binding site [DCCY T) T)(T NN(G G; D &#195;&#382; <br /> carried lacZ HIS3 genes reporters, driven                        C, Y 5 T C] (25) necessary sufficient copies 17-mer Gal4-binding sequence. Gal4-                           cell-cycle-regulated expression CLB2. 55-bp UAS Ndd1 fusion able activate transcription reporter                      similar 55-bp element SWI5 promoter constructs, resulting appearance His1 colonies                       sequence ability bind Mcm1-containing ternary expression b-galactosidase (data shown).                             complex (30). <br />    shown previously MCM1 participates                          addition Mcm1 consensus element (MCE) mechanism coordinates expression group genes                       Sff response element (SFRE) 55-bp UAS, (including CLB1, CLB2, SWI5) transcription ac-                         MCEs CLB2 promoter. relative positions <br />  VOL. 19, 1999                                                                  REGULATION LATE-S-PHASE GENES                 3319 <br />  <br />  <br />  <br />  <br />                                                           FIG. 3&#226;&#8364;&#8221;Continued. <br />  <br />  <br />  <br />  elements shown Fig. 6A. initial         pression progression cell cycle, cells <br /> experiments led suspect previously docu-         containing integrated copy 240-bp-driven ubiY lacZ <br /> mented 55-bp UAS (30) sufficient normal          synchronized G1 factor treatment cell-cycle-regulated expression CLB2. reasoned           allowed traverse cell cycle factor-free medium. <br /> MCEs contained sequences flanking 55-bp UAS          Total RNA isolated samples collected various required. compared 55-, 240-,        times analyzed presence lacZ endoge- 340-bp promoter fragments, contained             nous CLB2 RNAs Northern blotting. case cells MCEs, respectively, ability regulate tran-    arrested various stages cell cycle, pattern lacZ <br /> scription reporter gene. promoter fragments           expression synchronously cycling cells indistinguishable <br /> placed immediately upstream CYC1 TATA box linked             endogenous CLB2 gene (Fig. 6C), reporter gene ubiY lacZ (29), constructs        level lacZ expression lower second cycle. subsequently integrated chromosome URA3 locus        results suggest 240-bp promoter fragment, wild-type cells. Constructs UAS (&#226;&#8364;&#339;dead&#226;&#8364;?)        55-bp element, sufficient cell-cycle-regulated expres- 55-bp UAS SWI5 gene used negative pos-           sion CLB2. <br /> itive controls, respectively. determine pattern lacZ         240-bp fragment mediates potentiation CLB2 expres- <br /> expression various stages cell cycle, growth       sion NDD1 overexpression. 240-bp sequence wild-type cells carrying constructs arrested treat-    sufficient impose cell cycle regulation CLB2 transcrip- <br /> ment factor (late G1), hydroxyurea (early S phase),       tion, asked enhancement CLB2 expression <br /> nocodazole (pre-nuclear division). Total RNA prepared           excess Ndd1 effected promoter fragment. analyzed Northern blotting presence           compared efficacy 55-, 240-, lacZ endogenous CLB2 transcripts. 240-bp, 340-          340-bp fragments elicit upregulation CLB2 transcrip- <br /> bp, SWI5 UAS fragments able drive lacZ          tion. CEN vector carrying GAL-NDD1 introduced expression cycling, hydroxyurea (HU)- nocodazole             wild-type strains containing ubiY lacZ reporters driven (NOC)-arrested cells transcriptionally silent fac-    various promoter fragments (described preceding sec- <br /> tor-treated cells (Fig. 6B). expression pattern closely        tion) URA3 locus. cells grown raffinose <br /> matches endogenous CLB2 RNA,           medium induced express NDD1 2 h level lacZ transcription recombinant constructs     addition galactose. total RNA analyzed somewhat lower. 55-bp fragment CLB2 promoter,             presence lacZ endogenous CLB2 transcripts.  failed activate lacZ transcription instances     lacZ RNA detected reporter  <br /> (Fig. 6B). Identical results obtained reporter        struct control 55-bp fragment, 240- <br /> constructs tested 2mm vectors (results shown).          340-bp-fragment-driven reporters transcribed    confirm 240-bp fragment regulate lacZ ex-        readily detectable level (Fig. 7). transcription  3320       LOY ET AL.                                                                                                                          MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />    FIG. 4.   Overexpression NDD1 results enhanced expression CLB1, CLB2, SWI5. wild-type strain containing pGAL1-NDD1 grown mid-log <br /> phase raffinose medium. half culture continued grow raffinose medium (left lanes), half induced addition galactose express Ndd1 (right lanes). Total RNA prepared samples withdrawn 2-h intervals analyzed Northern blotting CLB1, CLB2, SWI5 <br /> transcripts. CLB3 CDC20 RNA transcripts shown comparison. (B) NDD1 overexpression does abrogate cell-cycle-regulated transcription CLB2. cdc15 cells carrying control plasmid (upper panel) plasmid harboring pGAL1-NDD1 (lower panel) synchronized telophase growth raffinose medium 37&#194;&#176;C 2 h. NDD1 expression induced 2 h addition galactose cells released galactose medium 25&#194;&#176;C. <br /> Samples withdrawn 15-min intervals analyzed Northern blotting CLB2-specific probe. total RNA loaded (30 mg) visualized methylene blue staining rRNAs. <br />  <br />  <br />  240- 340-bp constructs upregulated response                      sion Clb2. results far strongly suggest overexpression NDD1 (Fig. 7). strains tran-                     240-bp promoter fragment mediates cell-cycle-regu- <br /> scribed endogenous CLB2 gene  expected, ex-                          lated expression CLB2 potentiation excess Ndd1. <br /> pression enhanced Ndd1 overexpressed.                            determine Ndd1 recruited protein com- <br /> Ndd1 exerts effect CLB2 transcription 240-bp                         plexes assembled cis-regulatory sequence, radioac- <br /> promoter sequence.                                                                  tively labelled 240-bp fragment protein extract   Ndd1 prevents formation protein complexes                               cells expressing native-promoter-driven, fully functional HA3- <br /> 240-bp sequence, absence correlated expres-                          NDD1 analyzed gel mobility shift assay. assay <br />  <br />  <br />  <br />  <br />    FIG. 5.   NDD1 required normal expression CLB1, CLB2, SWI5. ndd1D::LEU2 cells carrying pGAL1-NDD1 grown log phase galactose <br /> medium. 3 h, NDD1 expression GAL1 promoter terminated transferring cells glucose medium. RNA samples taken 4, 6, 8, 10 h incubation glucose analyzed Northern blotting CLB1-, CLB2-, SWI5-specific probes. CLB3 CDC20 RNA transcripts shown comparison. (B) Overexpression CLB2 does suppress ndd1D::LEU2 null mutation. ndd1D::LEU2 cells, growth dependent wild-type <br /> NDD1 URA3 plasmid, transformed TRP1-based control vector TRP1 vector carrying GAL1-CLB2 GAL1-NDD1. Transformants streaked galactose medium containing 5-FOA counter-select URA3-based plasmid induce NDD1 expression GAL1 promoter. incubation 24&#194;&#176;C 3 days, cells carrying pGAL1-NDD1 survived. <br />  VOL. 19, 1999                                                                    REGULATION LATE-S-PHASE GENES                 3321 <br />  <br />  <br /> yielded specific complexes (designated  II, III, IV)       allowed determine timing degradation <br /> (Fig. 8A, left panel, lane 2), disappeared          timing stabilization. Cell extracts pre- <br /> challenged molar excess nonradioactive probe (Fig.          pared samples withdrawn various time points 8A, left panel, lane 6).  molar excess              release analyzed presence HA3-Ndd1 <br /> nonradioactive 55-bp fragment used challenge bind-         Clb2 proteins Western blotting. abundance ing, complex IV  extent complexes II)           Ndd1 protein begins decline 30 min release abrogated. suggests particular complex assem-       telophase arrest, cells begin disassemble mitotic <br /> bled core 55-bp region 240-bp fragment (Fig. 8A,        spindles (Fig. 8C). Ndd1 remains unstable cells enter right panel, lane 4). Complexes  II, IV contained Mcm1          new cycle 75 min, indicated absence anaphase inclusion anti-Mcm1 antibodies binding           spindles;  protein continues accumulate actions abolished formation (Fig. 8A, left panel, lane 5).      unstable 180 min, second cycle Mcm1 present complex III anti-Mcm1           spindle disassembly begins. timing Ndd1 degradation <br /> antibodies diminish, abolish, formation.            release telophase arrest matched closely  anti-HA antibodies failed supershift           endogenous Clb2, Clb2 accumulation showed complexes, indicating Ndd1 present com-          apparent delay 40 min (Fig. 8C). delay expected plexes (Fig. 8A, left panel, lanes 3 4). failure           experiment endogenous CLB2 gene, unlike <br /> anti-HA antibodies elicit supershift experiments        GAL1-driven NDD1, control native pro- general ineffectiveness gel retardation        moter transcribed significantly later Ndd1.  <br /> assays, antibodies (12CA5) shown          disappearance Ndd1 protein G1 correlates cause supershifts variety different contexts (37a).           silencing CLB2 transcription. <br />    Ndd1 does appear physically associate              rapid degradation Ndd1 exit mitosis protein assemblage 240-bp promoter sequence,              correlates appearance slow-migrating DNA- does modulate expression CLB2             protein complex (N) (Fig. 8B).  asked target genes? address question, compared         expression Ndd1 G1 abrogate formation pattern protein complexes formed 240-bp fragment            protein complex. pep42 cells carrying copies GAL- stages CLB2 promoter active              NDD1 integrated URA3 locus synchronized inactive. pep42 cells (US1005) arrested late G1 phase,        G1 factor treatment raffinose medium 2 h. half <br /> early S phase, mitosis treatment factor, HU,       culture induced express NDD1 addi- <br /> NOC, respectively. Cell extracts cultures used        tion galactose, half received glucose gel mobility shift assay 240-bp sequence           repress GAL1 promoter. 2 h, cell extracts pre- <br /> probe, total RNA analyzed presence             pared used combination 240-bp promoter <br /> CLB2 transcript. expected, cycling extract yielded        fragment gel mobility shift assay. G1 arrest induced specific protein complexes   II, III, IV), identical     factor maintained entire course ex- <br /> ones described preceding paragraph (Fig. 8B, lane 2).          periment. slow-migrating N complex com- bands detected extracts              plex III present glucose-grown cells, abun- <br /> HU-arrested cells, complexes  II, III absent        dance dramatically reduced cells expressing Ndd1 diminished NOC extracts (Fig. 8B, lanes 4 5). Inter-        GAL1 promoter (Fig. 8D, lanes 3 4), suggesting Ndd1 <br /> estingly, slow-migrating complex (N) detected factor       prevent formation protein complexes extract, conspicuously absent early-S-phase         CLB2 promoter. (Fig. 8B), N complex com- <br /> mitotic extracts (Fig. 8B, lane 3). Anti-Mcm1 antibodies abol-        peted anti-Mcm1 antibodies molar excess <br /> ish formation, suggesting complex contains         nonradioactive probe (Fig. 8D, lanes 5 6). Mcm1 (Fig. 8B, lane 7). expected, CLB2 expressed           overexpression Ndd1 diminishes complexes  II, G1  factor arrest), efficiently transcribed   III, suggesting presence Ndd1 G1 affects cycling HU- NOC-arrested cells (Fig. 8B, pan-           assembly. <br /> el).  appearance slow-migrating N complex             data suggest possible mechanism factor extracts correlates absence CLB2 RNA.            NDD1 participate regulation CLB2 expression. <br /> Similarly, high-level expression CLB2 NOC-arrested          According scheme, complexes N III act <br /> extracts concomitant dramatic reduction abun-        repressors CLB2 transcription, appearance dance complex III.                                                 inversely correlated expression CLB2. Ndd1    CLB2 transcription activated late S/G2 phase;         cause abrogation complexes N III (Fig. 8D) im- <br /> continues M phase switched        plies Ndd1 modulate CLB2 transcription prevent- cells exit mitosis enter G1 phase new cycle      ing formation repressor complexes, allow- <br /> (15, 53). Ndd1 required expression CLB2,       ing activation transcription.  rapid degradation <br /> wondered turning CLB2 transcription G1          Ndd1 G1, allow  enhance) assembly   caused absence Ndd1 protein.      various repressor complexes, constitute important step inquiry pertinent light observation        silencing CLB2 expression exit mitosis. <br /> CLB2 transcription shuts efficiently cells expressing     scheme particular focus GAL-NDD1 (Fig. 4B unpublished observations).               complexes N III, complexes II repres- determined relative stability Ndd1 protein           sor aggregates various protein compositions  like N cell cycle. cdc15 mutant cells carrying GAL-HA3-           complex, present protein extracts factor- <br /> NDD1 CEN plasmid (US1354) synchronized             arrested cells diminish abundance NOC extracts. <br /> late telophase incubation 37&#194;&#176;C 2 h raffinose             deletion analysis Ndd1. Based requirement dium. induced express HA3-Ndd1 2 h          Ndd1 CLB1, CLB2 SWI5 expression ability addition galactose allowed resume cell          activate transcription yeast hybrid assay, raised <br /> cycle progression 25&#194;&#176;C galactose medium. Constitutive           possibility Ndd1 act activator transcrip- <br /> expression Ndd1 GAL1 promoter experiment              tion. transcription activation heterologous context <br />     FIG. 6.   340-bp region CLB2 promoter. 59 flanking region CLB2 gene 2870 2520 bp shown. boxed region indicates presumptive 55-bp core promoter sequence. Mcm1 binding sites (MCE  II, III, IV, V) indicated arrows. Sff binding sites (SFRE) indicated dashed <br /> lines. endogenous XhoI site shown. (B) Cell-cycle-regulated CLB2 transcription requires 240-bp (2863 2627) CLB2 UAS. test UAS activity different stages cell cycle, cells carrying single, integrated copy various UAS-ubiY lacZ reporter fusions arrested factor (aF), HU, NOC. <br /> RNA samples taken analyzed Northern blotting lacZ CLB2 transcripts. total RNA loaded (30 mg) visualized methylene blue <br /> staining rRNAs. designations follows: dead, ubiY lacZ reporter UAS sequences; 55 bp, CLB2 UAS[2698 2643]-ubiY lacZ; 240 bp, CLB2 <br /> UAS[2863 2627]-ubiY lacZ; 340 bp, CLB2 UAS[2863 2523]-ubiY lacZ; SWI5, 55-bp SWI5 UAS-ubiY lacZ. (C) Pattern gene expression 240-bp CLB2 <br /> UAS endogenous CLB2 promoter. Cells carrying integrated copy 240-bp CLB2 UAS-ubiY lacZ reporter gene arrested G1 factor <br /> treatment (1 mg/ml) 24&#194;&#176;C allowed resume cell cycle progression medium factor. RNA samples collected 10-min intervals analyzed Northern blotting lacZ endogenous CLB2 RNA expression. total RNA loaded (30 mg) visualized methylene blue staining rRNAs. degree synchrony measured terms proportion cells anaphase spindles (lower panel). <br />  <br />  <br />  <br />  hybrid assay artifactual, asked                         possible Ndd1 serves transcription biological activity Ndd1  suppression                            activator cellular contexts. <br /> cdc28-1N mcm1 mutations) related ability ac- <br /> tivate transcription hybrid assay.                                                       DISCUSSION <br /> various constructs DNA-binding domain GAL4 transcription factor fused frame different                               activities cell cycle effectors regulated <br /> parts NDD1 ORF tested constructs                             protein modification, controls operating biological activity ability activate tran-                     level transcription. multitiered regulation pre- <br /> scription. deletion analysis expected identify                      sumably necessary order sharpen timing various regions important Ndd1 function.                                               cellular events progression division <br />    deletion constructs (Table 2) introduced                            cycle. cis-acting DNA sequences factors ac- <br /> yeast strain carrying lacZ reporter control                           tivate transcription genes START onset GAL4 UAS (US449), extent transcriptional activa-                            S phase described (23, 28, 37, 38). <br /> tion estimated quantitative measurement b-ga-                             transcriptional regulation late S/G2-phase- <br /> lactosidase activity. determine biological activity,                        specific genes poorly understood. far, Mcm1 hybrid fusions introduced ndd1D, cdc28-1N,                          putative transcription factor, Sff, shown partici- mcm1 mutants. evident Table 2, length                             pate control gene expression stage cell <br /> NDD1 fused GAL4 DNA-binding domain able                              cycle (1, 29).  Mcm1 required activate transcription suppress growth defects                              regulation number genes transcription ndd1D, cdc28-1N, mcm1 mutants (row 2). comparison                             periodic (31, 33, 51), unlikely Mcm1 itself various deletion mutants shows elimination                             major target cell cycle regulation. notion consistent <br /> C-terminal portion (residues 232 554; Table 2, rows 3, 4,                       finding Mcm1 occupies SWI5 CLB2 <br /> 5) results loss biological activity Ndd1 does                    promoters times, expression cyclic (1). diminish ability activate transcription.                             identified characterized new gene, NDD1, <br /> N-terminal protein sufficient transcriptional                       plays essential role expression late-S-phase <br /> activation biological function.                           genes CLB1, CLB2, SWI5, genes <br /> C-terminal half required Ndd1 function, itself                     transcribed absence.  new player biologically transcriptionally inactive (row 9). Inter-                       regulation gene expression late S phase. Ndd1 estingly, polyglutamine stretch N-terminal half,                        essential transcription CLB1 CLB2, conspicuous feature protein, dispensable                      excess enhances level expression. observation <br /> deletion does affect Ndd1 function, does elicit                        provide explanation ability Ndd1 suppress higher level transcription activation (row 12).                          cdc28-1N mutation. requirement NDD1 CLB1 <br /> sults imply ability Ndd1 activate transcription                      CLB2 expression argue lethality ndd1D hybrid assay unrelated biological function.                        mutant solely lack mitotic cyclins.  <br />  <br />                                                                                 3322 <br />                                                              FIG. 6&#226;&#8364;&#8221;Continued. <br />  <br />  <br />  <br />  <br /> overexpression CLB2 GAL1 promoter fails suppress nuclear-division defect NDD1-deficient cells <br /> (Fig. 5B), implying NDD1 necessary expression additional genes participate process nuclear <br /> division. NDD1 independently identified gene overexpression suppress crippling mutation SWI5 UAS, abolishes SWI5 transcription (29a). <br />    NDD1 expressed cell-cycle-stage-dependent manner expression peaks S phase just prior expression target gene CLB2 (Fig. 3A). impli- <br /> cate NDD1 critical factor timing CLB2 expres- <br /> sion. observation constitutive expression Ndd1 <br /> does alter cell-cycle-regulated pattern CLB2 tran- <br /> scription (Fig. 4B) suggests NDD1, necessary activation subset late-S-phase genes, crucial             FIG. 7. Enhancement CLB2 transcription excess Ndd1 requires determinant temporal control transcription.                 240-bp CLB2 UAS. Strains containing 55-, 240-, 340-bp CLB2 UAS-ubiY  constitutive expression Ndd1 leads                 lacZ reporter transformed pGAL1-NDD1 grown raffinose <br /> inefficient silencing CLB2 transcription late telophase               medium mid-log phase. Galactose added induce overexpression                                                                             NDD1 GAL1 promoter. RNA samples withdrawn galactose <br /> (unpublished observations), turning CLB2 transcrip-              induction  0 2 h, respectively) analyzed Northern blotting tion late telophase involve regulation Ndd1                   lacZ- CLB2-specific probes. total RNA loaded (30 mg) protein. conceivable inactivation Ndd1                visualized methylene blue staining rRNAs. <br />  <br />                                                                      3323 <br />  3324       LOY ET AL.                                                                                                                               MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />    FIG. 8.   DNA-protein complexes formed 240-bp CLB2 UAS contain Ndd1. Radioactively labelled double-stranded 240-bp CLB2 UAS probe used gel retardation assays. probe mixed 20 mg protein extracts prepared pep42 cells carrying native-promoter-driven HA3-NDD1. designations follows:  II, III, IV, specific DNA-protein complexes  II, III, IV; NS, nonspecific band; F, free probe. Antibody supershift reactions performed HA- Mcm1-specific antibodies (left panel, lanes 3, 4, 5). competition, excess nonradioactive 240- 55-bp competitor probe added reaction prior addition radiolabelled probe (left panel, lane 6; right panel, lanes 3 4). (B) Appearance N complex 240-bp CLB2 UAS coincides absence CLB2 expression. Exponentially growing (cyc) pep42 cells synchronized G1 phase, S phase, mitosis factor (aF), HU, NOC treatments, <br /> respectively. Protein extracts cultures incubated radiolabelled 240-bp CLB2 UAS probe (upper panel). Designations major, specific <br /> DNA-protein complexes panel  antibody supershift reaction performed Mcm1-specific antibodies (lane 7). RNA samples cultures analyzed Northern blotting CLB2-specific probe. total RNA loaded (30 mg) visualized methylene blue staining rRNAs. (C) <br /> HA-Ndd1 unstable G1. cdc15 cells carrying pGAL1-HA3-NDD1 synchronized telophase growth 37&#194;&#176;C released 25&#194;&#176;C resume cell <br /> cycle progression described text. Samples withdrawn 15-min intervals, stability HA-Ndd1 monitored Western blotting anti-HA <br /> antibodies (12CA5). Clb2 protein detected anti-Clb2 antibodies. Cdc28 protein, level remains constant cell cycle, shows <br /> equal loading samples lanes. (D) Conditional overexpression Ndd1 G1 prevents formation N complex. pep42 cells carrying integrated copies GAL1-NDD1 arrested G1 factor treatment raffinose medium 24&#194;&#176;C. 2 h, glucose added half culture, half induced 2 h express Ndd1 addition galactose. Protein extracts cells used gel retardation assay employing radiolabelled <br /> 240-bp CLB2 UAS probe. Antibody supershift performed Mcm1-specific antibodies (lane 5). competition, excess nonradioactive 240-bp competitor <br /> probe added reaction prior addition radiolabelled probe (lane 6). <br />  <br />  <br />  <br /> protein steps required switch CLB2                          ble G1, remains unclear. destruction-box-like <br /> expression end mitosis. instability Ndd1                       sequences middle region protein,  <br /> rapid degradation mitotic exit consistent                          moval did affect stability (unpublished results). notion (Fig. 8C). mechanism, renders Ndd1 unsta-                             important factor silencing CLB2 expression  VOL. 19, 1999                                                                                    REGULATION LATE-S-PHASE GENES                           3325 <br />  <br />  <br />                                                            TABLE 2. Deletion analysis Ndd1a <br />                                                                                                                                     Ability  <br />                                                                                b-Galactosidase activity <br /> Row                         Gal4-Ndd1 deletion mutants                                                          Complement            Suppress           Suppress <br />                                                                                    (Miller units) <br />                                                                                                                   ndd1D               cdc28-1N            mcm1 <br />  <br />   1                                                                                        0                         2                    2                 2 <br />  <br />   2                                                                                       25                         1                    1                 1 <br />   3                                                                                       86                         2                    2                 2 <br />  <br />   4                                                                                       59                         2                    2                 2 <br />  <br />   5                                                                                       33                         2                    2                 2 <br />  <br />   6                                                                                        0                         2                    2                 2 <br />  <br />   7                                                                                        0                         2                    2                 2 <br />  <br />   8                                                                                        0                         2                    2                 2 <br />  <br />   9                                                                                        0                         2                    2                 2 <br />  <br />  10                                                                                       41                         2                    2                 2 <br />  <br />  11                                                                                        0                         2                    2                 2 <br />  <br />  12                                                                                       76                         1                    1                 1 <br />  <br />  13                                                                                       79                         2                    2                 2 <br />  <br />  14                                                                                       88                         2                    2                 2 <br />       Various sequences NDD1 fused frame GAL4 DNA-binding domain (residues 1 147). fusions transformed strain containing lacZ reporter gene expression driven sequences bearing Gal4-binding sites. Gal4 DNA-binding domain (Gal4) used control. Numbers <br /> represent amino acid residues Ndd1 fused Gal4 DNA-binding domain. Polyglutamine domain deletions denoted DQ. Results b-galactosidase <br /> activities average independent assays. ability complement ndd1 null mutant tested growth glucose transforming fusion <br /> constructs ndd1D::LEU2 pGAL1-NDD1. suppression assays, fusion constructs introduced cdc28-1N mcm1 mutants, transfor- <br /> mants plated nonpermissive temperatures 37 35&#194;&#176;C, respectively. <br />  <br />  <br />  <br />  <br /> Cdc28-Clb kinase itself. previously shown                         activation CLB2 transcription. Cdc28-Clb kinase complex stimulates CLB2 expression                          differences regulatory sequences positive feedback loop (4). Consequently, inactivation                      promoter sequence elements kinase abrupt proteolysis Clb proteins M/G1                       embedded. <br /> transition lead rapid decline CLB2 expression.                          240-bp promoter fragment promotes assembly    genetic interaction MCM1 ability                         prominent protein complexes. exact composi- <br /> hance CLB1, CLB2, SWI5 transcription lead suspect                        tion complexes remains unknown, appear NDD1 influence gene expression modulating                        contain Mcm1 (Fig. 8A). Extracts prepared cells travers- <br /> promoter activity. course studies, discov-                    ing synchronously cell cycle capable assem- <br /> ered previously reported 55-bp UAS (30) CLB2                       bling, albeit various extents, complexes CLB2 <br /> promoter, contains pair regulatory sites comprised                      promoter fragment (data shown). Interestingly, Ndd1 MCE SFRE, unable drive expression                         recruited protein complexes, suggested reporter gene assay  Materials                          gel mobility shift assay (Fig. 8A), despite requirement <br /> Methods). identical assay, 55-bp UAS SWI5 gene                        CLB1, CLB2, SWI5 transcription ability elicited transcription showed expected                       enhance gene expression. immunoprecipitation experi- <br /> pattern expression cell cycle. suggests                    ments, Ndd1 associates Mcm1 inactivity 55-bp CLB2 UAS experiments                     major components general transcription machinery faulty assay  investigations,                   yeast TBP, TAF145, TAF90 (unpublished data). identified 240-bp fragment sufficient                       observations suggest Ndd1 cooperates indirectly expression cell cycle regulation CLB2. 240-bp                       transcriptional apparatus, possibly intermediary pro- <br /> sequence contains 55-bp presumptive UAS                          teins, regulate expression late-S-phase genes. pair MCE SFRE flanked additional                              does Ndd1 exert effect gene expression? MCE (Fig. 6A) (reference 1 study). configuration                     possibility Ndd1 effector Cdc28-Clb kinase capable mediating transcriptional enhancement                       activity affects CLB2 transcription modifying caused overexpression Ndd1; 55-bp UAS                          efficacy positive-feedback loop.  hand, remains unresponsive (Fig. 7). CLB1                         unlikely, Ndd1-depleted cells NOC  <br /> promoter harbors pairs MCE SFRE                          duced arrest contain significant levels mitotic kinase <br /> spatial arrangement identical CLB2 pro-                      activity transcribe CLB2 (unpublished results). <br /> moter (1). intriguing set MCE SFRE                        Alternatively, Ndd1 prevent repressor binding appropriately regulate SWI5 expression, sufficient                   CLB2 promoter, allowing activation transcrip- <br />  3326        LOY ET AL.                                                                                                                                  MOL. CELL. BIOL. <br />  <br />  <br /> tion. finding Mcm1, activator transcription,                              12. Company, M., C. Adler, B. Errede. 1988. Identification Ty1 regu- <br /> occupies CLB2 promoter cell cycle (1)                                     latory sequence responsive STE7 STE12. Mol. Cell. Biol. 8:2545&#226;&#8364;&#8220; <br />                                                                                              2554. <br /> strengthens possibility repressor                              13. Cross, F.,  H. Tinkelenberg. 1991. positive feedback loop controlling <br /> responsible termination CLB2 transcription G1.                              CLN1 CLN2 gene expression START yeast cell cycle. Cell context Ndd1 function, repressor model consistent                             65:875&#226;&#8364;&#8220;883. findings:   new protein complex N                                14. Epstein, C. B., F. Cross. 1992. CLB5: novel B type cyclin yeast <br />                                                                                              role S-phase. Genes Dev. 6:1695&#226;&#8364;&#8220;1706. <br /> detected 240-bp promoter fragment G1                                  15. Fitch, , C. Dahman, U. Surana,  Amon, L. Goetsh, B. Byers, B. <br /> CLB2 transcription abruptly switched  (ii) complex                            Futcher. 1992. Characterization B-type cyclin genes budding <br /> undetectable HU- NOC-arrested cells CLB2                                      yeast S. cerevisiae. Mol. Biol. Cell 3:805&#226;&#8364;&#8220;818. <br /> actively transcribed; (iii) overexpression Ndd1 G1 abol-                           16. Ghiara, J. B., H. E. Richardson, K. Sugimoto, M. Henze, D. J. Lew, C. <br />                                                                                              Wittenberg, S.  Reed. 1991. cyclin B homolog S. cerevisiae. Chronic <br /> ishes formation N complex; (iv) wild-type                                  activation Cdc28 protein kinase cyclin prevents exit mitosis. <br /> cells, Ndd1 rapidly degraded G1, concomitant                                  Cell 65:163&#226;&#8364;&#8220;174. <br /> silencing CLB2 expression. Complex III behaves like com-                              17. Ghislain, M.,  Udvardy, C. Mann. 1993. S. cerevisiae 26S protease <br /> plex N abundance enhanced G1, dramati-                                 mutants arrest cell division G2/metaphase. Nature (London) 366:358&#226;&#8364;&#8220;362. <br />                                                                                          18. Glotzer, M.,  W. Murray, M. W. Kirshner. 1991. Cyclin degraded cally reduced NOC-induced arrest CLB2 max-                                    ubiquitin pathway. Nature (London) 349:132&#226;&#8364;&#8220;138. <br /> imally transcribed, negatively influenced                                     19. Gu, Y., J. Rosenblatt, D. O. Morgan. 1992. Cell cycle regulation overexpression Ndd1.  complexes N III                                   CDK2 activity phosphorylation Thr160 Tyr15. EMBO J. 11:3995&#226;&#8364;&#8220; <br /> repressor assemblages capable terminating CLB2 expres-                                    4005. <br />                                                                                          20. Hartwell, L. H., J. R. Culotti, B. J. Reid. 1974. Genetic control cell <br /> sion. presence Ndd1 abolishes formation                                  cycle yeast. Science 183:46&#226;&#8364;&#8220;51. presumptive repressor complexes, overexpression                               21. Kilmartin, J. V.,  E. M. Adams. 1984. Structural arrangements does elicit CLB2 expression G1. implies lack                              tubulin actin cell cycle yeast Saccharomyces cerevisiae. Ndd1 protein sole reason termination                               J. Cell Biol. 98:922&#226;&#8364;&#8220;933. <br />                                                                                          22. Koch, C., K. Nasmyth. 1994. Cell cycle regulated transcription yeast. CLB2 transcription; progressive weakening positive-                              Curr. Opin. Cell Biol. 6:451&#226;&#8364;&#8220;459. <br /> feedback loop proteolysis Clb proteins                               23. Koch, C., T. Moll, M. Neuberg, H. Ahorn, K. Nasmyth. 1993. role critical. nature hypothetical repressor far                                 transcription factors Mbp1 Swi4 progression G1 S phase. <br /> unknown. identify repressor, embarked                                      Science 261:1551&#226;&#8364;&#8220;1557. <br />                                                                                          24. Kotani, S., S. Tugendreich, M. Fujii, P. M. Jorgensen, N. Watanabe, C. genetic screen isolate mutations lead                                 Hoog, P. Hieter, K. Todokoro. 1998. PKA MPF-activated polo-like <br /> inappropriate CLB2 expression G1.                                                         kinase regulate anaphase-promoting complex activity mitosis progres- <br />    identification NDD1, added new                                      sion. Mol. Cell 1:371&#226;&#8364;&#8220;380. <br /> element regulation gene expression late S phase.                            25. Kuo, M.-H., E. J. Grayhack. 1994. library yeast genomic Mcm1 <br />                                                                                              binding sites contains genes involved cell cycle control, cell wall  investigations required uncover                              membrane structure, metabolism. Mol. Cell. Biol. 14:348&#226;&#8364;&#8220;359. <br /> mechanism ensures correct timing onset                               26. Kuo, M.-H., E. T. Nadeau, E. J. Grayhack. 1997. Multiple phosphory- <br /> termination expression genes.                                                lated forms Saccharomyces cerevisiae Mcm1 protein include isoform <br />                                                                                              induced response high salt concentrations. Mol. Cell. Biol. 17:819&#226;&#8364;&#8220;832. <br />                                                                                          27. Lim, H. H., C. J. Loy, S. Zaman, U. Surana. 1996. Dephosphorylation                            ACKNOWLEDGMENTS <br />                                                                                              threonine 169 Cdc28 required exit mitosis   thank Kim Nasmyth, laboratory plasmid containing                           necessary START Saccharomyces cerevisiae. Mol. Cell. Biol. 16:4573&#226;&#8364;&#8220; <br /> NDD1 isolated U.S. grateful Gustav Ammerer                            4583. various strains, anti-Mcm1 antibodies, suggestions, fruitful                     28. Lowndes, N. F.,  L. Johnson, L. Breeden, L. H. Johnston. 1992. Swi6 <br />                                                                                              protein required transcription periodically expressed DNA <br /> discussions.                                                                                 synthesis genes budding yeast. Nature (London) 357:505&#226;&#8364;&#8220;508. <br />   work supported National Science Technology                         29. Lydall, D., G. Ammerer, K. Nasmyth. 1991. new role MCM1 Board, Singapore.                                                                            yeast: <br /> </body></html>